Avelumab is indicated for:
Metastatic Merkel cell carcinoma (MCC)
Irrespective of gender only Adults (18 years old or older)
Avelumab is indicated as monotherapy for the treatment of adult patients with metastatic Merkel cell carcinoma (MCC).
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Intravenous - 10 mg/kg once every 2 weeks
Active ingredient Avelumab is contraindicated in the following cases: